Envoy Medical (COCH) Accumulated Expenses (2021 - 2026)

Envoy Medical (COCH) has 6 years of Accumulated Expenses data on file, last reported at $9.7 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses rose 90.88% year-over-year to $9.7 million; the trailing twelve-month figure through Mar 2026 stood at $9.7 million (up 90.88% YoY), and the FY2025 full-year result was $334000.0, up 63.73% from the prior year.
• Accumulated Expenses grew to $9.7 million in Q1 2026, from $334000.0 in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $9.7 million in Q1 2026 to a low of $204000.0 in Q4 2024.
• A 5-year average of $3.7 million and a median of $4.1 million in 2023 frame the typical range for Accumulated Expenses.
• Across the five-year window, Accumulated Expenses soared 658.72% in 2023 and tumbled 95.58% in 2024, its largest moves.
• Tracing COCH's Accumulated Expenses over 5 years: stood at $608000.0 in 2022, then soared by 658.72% to $4.6 million in 2023, then plunged by 95.58% to $204000.0 in 2024, then jumped by 63.73% to $334000.0 in 2025, then jumped by 2790.12% to $9.7 million in 2026.
• Business Quant data shows COCH's Accumulated Expenses at $9.7 million in Q1 2026, $334000.0 in Q4 2025, and $665000.0 in Q3 2025.